Kunitz O, Lösing R, Schulz-Stübner S, Haaf-Von-Below S, Rossaint R, Kuhlen R
Klinik für Anästhesiologie am Universitätsklinikum der RWTH Aachen, Germany.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2004 Jan;39(1):10-4. doi: 10.1055/s-2004-815712.
A disadvantage of Propofol (commercial preparation containing long-chain triglycerides; Propofol-LCT) is pain on injection, which is reported by 54 - 100 % of the patients. Many different approaches have been used in an attempt to decrease the pain on injection of propofol. The currently most efficacious treatment is lidocaine given intravenously with a tourniquet prior to Propofol injection. In previous studies, larger concentrations of free propofol in the aqueous phase of an emulsion were associated with more pain on injection. A new formulation of propofol (a mixture of long-chain and medium-chain triglycerides in the carrier emulsion; Propofol-MCT/LCT) reduces the incidence of pain on bolus injection. This study was designed to investigate, whether the use of Propofol-MCT/LCT alleviates pain on injection to a similar degree as pretreatment with lidocaine.
Eighty patients (ASA I - III) were randomly assigned to four groups according to a double-blinded protocol, to receive either lidocaine 2 % or normal saline given iv. with a 60 seconds tourniquet time before the injection of Propofol-LCT or Propofol-MCT/LCT. (group 1: 2 ml NaCl 0,9 %, Propofol-LCT; group 2: 2 ml NaCl 0,9 %, Propofol-MCT/LCT; group 3: 2 ml lidocaine 2 %, Propofol-LCT; group 4: 2 ml lidocaine 2 %, Propofol-MCT/LCT). Assessment of pain on injection was performed after 30 % of the induction dose was given.
Pain on injection caused by Propofol-LCT with pre-treatment of lidocaine and Propofol-MCT/LCT alone is shown to be equivalent. Comparison of Propofol-MCT/LCT with pre-treatment of lidocaine and Propofol-LCT alone shows a statistical noticeable p-value of 0.035. Propofol-MCT/LCT with pre-treatment of lidocaine suggests a tendency of causing less pain compared to Propofol-MCT/LCT. Analysis of the postoperative questionnaire supplies no significant difference.
The results suggest that pain on injection is reduced equivalent using either Propofol-MCT/LCT alone or Propofol-LCT with pre-treatment of lidocaine. Pre-treatment with lidocaine before Propofol-MCT/LCT seems to have an additional effect.
丙泊酚(含长链甘油三酯的商业制剂;丙泊酚-LCT)的一个缺点是注射时疼痛,据报道54%-100%的患者会出现这种情况。人们尝试了许多不同方法来减轻丙泊酚注射时的疼痛。目前最有效的治疗方法是在注射丙泊酚前静脉注射利多卡因并使用止血带。在先前的研究中,乳剂水相中游离丙泊酚浓度越高,注射时疼痛越明显。丙泊酚的一种新制剂(载体乳剂中长链和中链甘油三酯的混合物;丙泊酚-MCT/LCT)可降低推注时疼痛的发生率。本研究旨在调查丙泊酚-MCT/LCT减轻注射疼痛的程度是否与利多卡因预处理相似。
80例美国麻醉医师协会(ASA)分级为I-III级的患者按照双盲方案随机分为四组,在注射丙泊酚-LCT或丙泊酚-MCT/LCT前静脉注射2%利多卡因或生理盐水,并使用止血带60秒。(第1组:2ml 0.9%氯化钠注射液,丙泊酚-LCT;第2组:2ml 0.9%氯化钠注射液,丙泊酚-MCT/LCT;第3组:2ml 2%利多卡因,丙泊酚-LCT;第4组:2ml 2%利多卡因,丙泊酚-MCT/LCT)。在给予诱导剂量的30%后评估注射时的疼痛情况。
单独使用利多卡因预处理的丙泊酚-LCT和单独使用丙泊酚-MCT/LCT引起的注射疼痛相当。丙泊酚-MCT/LCT与单独使用利多卡因预处理的丙泊酚-LCT相比,p值具有统计学意义(p = 0.035)。与单独使用丙泊酚-MCT/LCT相比,利多卡因预处理的丙泊酚-MCT/LCT有引起更少疼痛的趋势。术后问卷调查分析无显著差异。
结果表明,单独使用丙泊酚-MCT/LCT或利多卡因预处理的丙泊酚-LCT减轻注射疼痛的效果相当。在丙泊酚-MCT/LCT之前使用利多卡因预处理似乎有额外的效果。